Ganoderan (GDN) Regulates The Growth, Motility And Apoptosis Of Non-Small Cell Lung Cancer Cells Through ERK Signaling Pathway In Vitro And In Vivo

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. doi:10.3322/caac.2138728055103
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi:10.1002/ijc.2921025220842
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Testa U, Castelli G, Pelosi E. Lung cancers: molecular characterization, clonal heterogeneity and evolution, and cancer stem cells. Cancers. 2018;10(8):E248. doi:10.3390/cancers1008024830060526
   PubMed Web of Science ®Google Scholar
• Carmichael JA, Wing-San Mak D, O’Brien M. A review of recent advances in the treatment of elderly and poor performance NSCLC. Cancers. 2018;10(7):E236. doi:10.3390/cancers1007023630021993
   PubMed Web of Science ®Google Scholar
• Shang J, Xu YD, Zhang YY, Li M. Long noncoding RNA OR3A4 promotes cisplatin resistance of non-small cell lung cancer by upregulating CDK1. Eur Rev Med Pharmacol Sci. 2019;23(10):4220–4225. doi:10.26355/eurrev_201905_1792631173293
   PubMed Web of Science ®Google Scholar
• Patel JD, Paz-Ares L, Zinner RG, Barlesi F, Koustenis AG, Obasaju CK. Pemetrexed Continuation Maintenance phase III trials in non-squamous non-small cell lung cancer: focus on 2-year overall survival and continuum of care. Clin Lung Cancer. 2018;19(6):E823–E830. doi:10.1016/j.cllc.2018.05.01330369427
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang Y, Zhang M, Zhang L. Ganoderma sinense polysaccharide: an adjunctive drug used for cancer treatment. Prog Mol Biol Transl Sci. 2019;163:165–177.31030747
   PubMed Web of Science ®Google Scholar
• Zeng P, Chen Y, Zhang L, Xing M. Ganoderma lucidum polysaccharide used for treating physical frailty in China. Prog Mol Biol Transl Sci. 2019;163:179–219.31030748
   PubMed Web of Science ®Google Scholar
• Zhu J, Xu J, Jiang LL, et al. Improved antitumor activity of cisplatin combined with Ganoderma lucidum polysaccharides in U14 cervical carcinoma-bearing mice. Kaohsiung J Med Sci. 2019;35(4):222–229. doi:10.1002/kjm2.1202030958641
   PubMed Web of Science ®Google Scholar
• Guo J, Yuan C, Huang M, et al. Ganoderma lucidum-derived polysaccharide enhances coix oil-based microemulsion on stability and lung cancer-targeted therapy. Drug Deliv. 2018;25(1):1802–1810. doi:10.1080/10717544.2018.151600630343605
   PubMed Web of Science ®Google Scholar
• Wu K, Na K, Chen D, Wang Y, Pan H, Wang X. Effects of non-steroidal anti-inflammatory drug-activated gene-1 on Ganoderma lucidum polysaccharides-induced apoptosis of human prostate cancer PC-3 cells. Int J Oncol. 2018;53(6):2356–2368. doi:10.3892/ijo.2018.457830272272
   PubMed Web of Science ®Google Scholar
• Hikino H, Konno C, Mirin Y, Hayashi T. Isolation and hypoglycemic activity of Ganoderans A and B, glycans of Ganoderma lucidum fruit bodies1. Planta Med. 1985;51(04):339–340. doi:10.1055/s-2007-96950717340529
   PubMedGoogle Scholar
• Tomoda M, Gonda R, Kasahara Y, Hikino H. Glycan structures of ganoderans b and c, hypoglycemic glycans of ganoderma lucidum fruit bodies. Phytochemistry. 1986;25(12):2817–2820. doi:10.1016/S0031-9422(00)83748-6
   Web of Science ®Google Scholar
• Hikino H, Ishiyama M, Suzuki Y, Konno C. Mechanisms of hypoglycemic activity of ganoderan B: a glycan of Ganoderma lucidum fruit bodies. Planta Med. 1989;55(5):423–428. doi:10.1055/s-2006-9620572682700
   PubMedGoogle Scholar
• Zhong WD, He HC, Ou RB, et al. Protective effect of ganoderan on renal damage in rats with chronic glomerulonephritis. Clin Invest Med. 2008;31(4):E212–E217. doi:10.25011/cim.v31i4.478218682045
   PubMed Web of Science ®Google Scholar
• Liu HY, Chen CY, Hung YF, et al. RNase A promotes proliferation of neuronal progenitor cells via an ERK-dependent pathway. Front Mol Neurosci. 2018;11:428. doi:10.3389/fnmol.2018.0042830534052
   PubMed Web of Science ®Google Scholar
• Li J, Guo Y, Duan L, et al. AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signaling. Oncotarget. 2017;8(20):33694–33703. doi:10.18632/oncotarget.1662428402270
   PubMedGoogle Scholar
• Sun Y, Liu WZ, Liu T, Feng X, Yang N, Zhou HF. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res. 2015;35(6):600–604. doi:10.3109/10799893.2015.103041226096166
   PubMed Web of Science ®Google Scholar
• Wu D, Li M, Gao Y, et al. Peptide V3 inhibits the growth of human hepatocellular carcinoma by inhibiting the Ras/Raf/MEK/ERK signaling pathway. J Cancer. 2019;10(7):1693–1706. doi:10.7150/jca.2921131205525
   PubMed Web of Science ®Google Scholar
• Chen Y, Tang Y, Tang Y, Yang Z, Ding G. Serine protease from nereis virens inhibits H1299 lung cancer cell proliferation via the PI3K/AKT/mTOR pathway. Mar Drugs. 2019;17(6):E366. doi:10.3390/md1706036631226829
   PubMed Web of Science ®Google Scholar
• Wei CH, Wu G, Cai Q, et al. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway. J Hematol Oncol. 2017;11(1):6. doi:10.1186/s13045-017-0546-4
   Google Scholar
• Milovic V, Teller IC, Murphy GM, Caspary WF, Stein J. Deoxycholic acid stimulates migration in colon cancer cells. Eur J Gastroenterol Hepatol. 2001;13(8):945–949. doi:10.1097/00042737-200108000-0001211507360
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.2126225651787
   PubMed Web of Science ®Google Scholar
• Liu G, Pei F, Yang F, et al. Role of autophagy and apoptosis in non-small-cell lung cancer. Int J Mol Sci. 2017;18(2):E367. doi:10.3390/ijms1802036728208579
   PubMed Web of Science ®Google Scholar
• Johung KL, Yeh N, Desai NB, et al. Extended survival and prognostic factors for patients with ALK-rearranged non-small-cell lung cancer and brain metastasis. J Clin Oncol. 2016;34(2):123–129. doi:10.1200/JCO.2015.62.013826438117
   PubMed Web of Science ®Google Scholar
• Zhang S, Pang G, Chen C, et al. Effective cancer immunotherapy by Ganoderma lucidum polysaccharide-gold nanocomposites through dendritic cell activation and memory T cell response. Carbohydr Polym. 2019;205:192–202. doi:10.1016/j.carbpol.2018.10.02830446095
   PubMed Web of Science ®Google Scholar
• Pan H, Wang Y, Na K, et al. Autophagic flux disruption contributes to Ganoderma lucidum polysaccharide-induced apoptosis in human colorectal cancer cells via MAPK/ERK activation. Cell Death Dis. 2019;10(6):456. doi:10.1038/s41419-019-1653-731186406
   PubMedGoogle Scholar
• Zhang K, Liu Y, Zhao X, et al. Anti-inflammatory properties of GLPss58, a sulfated polysaccharide from Ganoderma lucidum. Int J Biol Macromol. 2018;107(Pt A):486–493. doi:10.1016/j.ijbiomac.2017.09.01528890375
   PubMedGoogle Scholar
• Wang J, Cao B, Zhao H, Feng J. Emerging roles of ganoderma lucidum in anti-aging. Aging Dis. 2017;8(6):691–707. doi:10.14336/AD.2017.041029344411
   PubMed Web of Science ®Google Scholar
• Zheng J, Yang B, Yu Y, Chen Q, Huang T, Li D. Ganoderma lucidum polysaccharides exert anti-hyperglycemic effect on streptozotocin-induced diabetic rats through affecting beta-cells. Comb Chem High Throughput Screen. 2012;15(7):542–550. doi:10.2174/13862071280161916822329512
   PubMed Web of Science ®Google Scholar
• Jin H, Jin F, Jin JX, et al. Protective effects of Ganoderma lucidum spore on cadmium hepatotoxicity in mice. Food Chem Toxicol. 2013;52:171–175. doi:10.1016/j.fct.2012.05.04022659462
   PubMed Web of Science ®Google Scholar
• Wang C, Shi S, Chen Q, et al. Antitumor and Immunomodulatory activities of Ganoderma lucidum polysaccharides in glioma-bearing rats. Integr Cancer Ther. 2018;17(3):674–683. doi:10.1177/153473541876253729607690
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhou D, Liu Y, et al. Ganoderma lucidum polysaccharide inhibits prostate cancer cell migration via the protein arginine methyltransferase 6 signaling pathway. Mol Med Rep. 2018;17(1):147–157. doi:10.3892/mmr.2017.790429115463
   PubMed Web of Science ®Google Scholar
• Tao L, Wang S, Zhao Y, et al. Phenolcarboxylic acids from medicinal herbs exert anticancer effects through disruption of COX-2 activity. Phytomedicine. 2014;21(11):1473–1482. doi:10.1016/j.phymed.2014.05.00124916702
   PubMed Web of Science ®Google Scholar
• Liu QQ, Zhang FF, Wang F, et al. TIPE2 inhibits lung cancer growth attributing to promotion of apoptosis by regulating some apoptotic molecules expression. PLoS One. 2015;10(5):e0126176. doi:10.1371/journal.pone.012617625946186
   PubMed Web of Science ®Google Scholar
• Tang F, Tang S, Guo X, Yang C, Jia K. CT45A1 siRNA silencing suppresses the proliferation, metastasis and invasion of lung cancer cells by downregulating the ERK/CREB signaling pathway. Mol Med Rep. 2017;16(5):6708–6714. doi:10.3892/mmr.2017.746628901509
   PubMed Web of Science ®Google Scholar
• Yue SJ, Zhang PX, Zhu Y, et al. A ferulic acid derivative FXS-3 inhibits proliferation and metastasis of human lung cancer A549 cells via positive JNK signaling pathway and negative ERK/p38, AKT/mTOR and MEK/ERK signaling pathways. Molecules. 2019;24(11):E2165. doi:10.3390/molecules2411216531181779
   PubMed Web of Science ®Google Scholar
• Chang L, Fang S, Chen Y, et al. Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway. Lipids Health Dis. 2019;18(1):118. doi:10.1186/s12944-019-1058-831122252
   PubMedGoogle Scholar
• Jiang M, Zhou LY, Xu N, An Q. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways. Thorac Cancer. 2019;10(6):1319–1333. doi:10.1111/1759-7714.1301931055884
   PubMed Web of Science ®Google Scholar